# Zhejiang Haizhou Pharmaceutical Co., Ltd. – FDA Inspection, Jan 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-haizhou-pharmaceutical-co-ltd/139402a5-b290-46e5-816b-f7d5f1e6ec75
Source feed: FDA_Inspections

> FDA inspection 1078048 of Zhejiang Haizhou Pharmaceutical Co., Ltd., January 18, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1078048
- Company Name: Zhejiang Haizhou Pharmaceutical Co., Ltd.
- Inspection Date: 2019-01-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1271224 - 2025-04-18
- [FDA Inspection 893991 - 2014-08-07](https://www.keypedia.com/records/fda_inspections/zhejiang-haizhou-pharmaceutical-co-ltd/bede4e3b-cfb5-4a1a-9a17-f1dccd085ac7)
- FDA Inspection 742581 - 2011-06-30

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/zhejiang-haizhou-pharmaceutical-co-ltd/620d9797-98f1-4126-a139-c1526cbac110

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c